{Reference Type}: Case Reports
{Title}: Fibrothecoma a rare ovarian tumor: A case report.
{Author}: Flissate F;Bensrhir I;Mahfoud H;Lakhdar A;Baidada A;Sassi S;
{Journal}: Int J Surg Case Rep
{Volume}: 120
{Issue}: 0
{Year}: 2024 Jul 20
暂无{DOI}: 10.1016/j.ijscr.2024.109771
{Abstract}: <B>UNASSIGNED: </B>Fibroma, thecoma, and fibrothecoma collectively denote a range of non-cancerous sex cord-stromal tumors distinguished by the presence of fibroblastic stromal cells and/or cells resembling luteinized theca cells.<BR><B>METHODS: </B>In this report, we present a case study of a 52-year-old patient in whom this uncommon tumor was identified via MRI, highlighting the distinctive diagnostic and treatment considerations associated with it.<BR><B>UNASSIGNED: </B>Ovarian fibrothecoma tumors are infrequent, constituting less than 4 % of all ovarian tumors. Although they may manifest at any age, they are more commonly observed in elderly and post-menopausal individuals. Diagnosis hinges on clinical and paraclinical data, yet definitive confirmation is predominantly achieved through anatomopathological examination. For younger patients, conservative surgery is usually favored, whereas peri- or post-menopausal individuals may undergo radical treatment.<BR><B>CONCLUSIONS: </B>Ovarian Fibrothecoma, though rare, are typically benign tumors frequently found in older patients. Diagnosis primarily relies on histological examination. Fortunately, the prognosis for these tumors is generally favorable.